GreenMark Biomedical has a total of 34 patents globally, out of which 9 have been granted. Of these 34 patents, more than 64% patents are active. The United States of America is where GreenMark Biomedical has filed the maximum number of patents, followed by Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of GreenMark Biomedical.
GreenMark Biomedical was founded in 2016. GreenMark Biomedical is a health care company. It creates technologies using tiny biopolymer particles made from starch intended for food use. The company’s diagnostic device is used by dental practitioners as part of a standard dental exam to assess and monitor non-invasive treatment of dental caries.
Do read about some of the most popular patents of GreenMark Biomedical which have been covered by us in this article and also you can find GreenMark Biomedical patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over GreenMark Biomedical patent portfolio.
How many patents does GreenMark Biomedical have?
GreenMark Biomedical has a total of 34 patents globally. These patents belong to 8 unique patent families. Out of 34 patents, 22 patents are active.
How Many Patents did GreenMark Biomedical File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | GreenMark Biomedical Applications Filed | GreenMark Biomedical Patents Granted |
2023 | 1 | 1 |
2022 | 3 | 1 |
2021 | 1 | 1 |
2020 | 5 | 2 |
2019 | 12 | 1 |
2016 | – | 2 |
2015 | – | 1 |
2012 | 4 | – |
2011 | 8 | – |
How many GreenMark Biomedical patents are Alive/Dead?
Worldwide Patents
How Many Patents did GreenMark Biomedical File in Different Countries?
Countries in which GreenMark Biomedical Filed Patents
Country | Patent |
United States Of America | 14 |
Canada | 4 |
Europe | 3 |
Australia | 3 |
Japan | 2 |
Austria | 1 |
Brazil | 1 |
Germany | 1 |
Where are Research Centers of GreenMark Biomedical Patents Located?
The Research Centers of GreenMark Biomedical Patents is the United States of America.
10 Best GreenMark Biomedical Patents
US20120141551A1 is the most popular patent in the GreenMark Biomedical portfolio. It has received 13 citations so far from company like Ecosynthetix, Mcafee.
Below is the list of 10 most cited patents of GreenMark Biomedical:
Publication Number | Citation Count |
US20120141551A1 | 13 |
US10285943B2 | 6 |
US20190339279A1 | 5 |
US20190298660A1 | 3 |
US20130090467A1 | 3 |
US20210321864A1 | 2 |
US20210169403A1 | 2 |
WO2020051352A1 | 2 |
US11369570B2 | 1 |
What Percentage of GreenMark Biomedical US Patent Applications Were Granted?
GreenMark Biomedical (Excluding its subsidiaries) has filed 8 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 33.33%.
Below are the key stats of GreenMark Biomedical patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for GreenMark Biomedical?
Law Firm | Total Applications | Success Rate |
Borden Ladner Gervais Llp | 8 | 33.33% |
List of GreenMark Biomedical patents
GreenMark Biomedical Patents | Title |
US20120141551A1 | Phosphate Crosslinked Starch Nanoparticle And Dental Treatments |
US10285943B2 | Aptamer Bioconjugate Drug Delivery Device |
US20190339279A1 | Aptamer Bioconjugate Drug Delivery Device |
US20190298660A1 | Phosphate Crosslinked Starch Nanoparticle And Dental Treatments |
US20130090467A1 | Bisphosphonate Loaded Starch Nanoparticle |
US20210321864A1 | Humectant And/Or Buffered Starch Compositions And Use In Oral Care Such As Treating Xerostomia |
US20210169403A1 | Aptamer Bioconjugate Drug Delivery Device |
WO2020051352A1 | Dental Imaging And/Or Curing System |
US11369570B2 | Aptamer Bioconjugate Drug Delivery Device |
US11666515B2 | Drug Delivery Device For An Aptamer Bioconjugate |
US20230277423A1 | Dental Imaging And/Or Curing System |
US20220370372A1 | Phosphate Crosslinked Starch Nanoparticle And Dental Treatments |
US20220288116A1 | Aptamer Bioconjugate Drug Delivery Device |
US20210338585A1 | Dental Imaging System And Image Analysis |
EP2645991B1 | Phosphate Crosslinked Starch Nanoparticle And Dental Treatments |
DE602011065006T2 | Aptamer Bioconjugate Drug Delivery Device |
EP3847442A4 | Aptamer Bioconjugate Drug Delivery Device |
EP3773751A4 | Aptamer Bioconjugate Drug Delivery Device |
CA2819240C | Dental Imaging System And Image Analysis |
CA3210287A1 | Aptamer Bioconjugate Drug Delivery System |
CA3090303A1 | Phosphate-Crosslinked Starch Nanoparticles And Dental Treatment |
CA2790763A1 | Methods For Manufacturing Nanoparticles, For Treatment Of Teeth, And For Manufacturing A Biopolymer Nanoparticle, Nanoparticles, Use Of The Nanoparticles, Starch Nanoparticle Cross-Cutted With Polyphosphate, And, Use Of A Starch Nanoparticle Cross-Cutted With Polyphosphate. |
AU2012318273B2 | Method Of Detecting Cracks In Teeth |
AU2011336352B2 | Aptamer Bioconjugate Drug Delivery Device |
AU2022229909A1 | Detecting Nitroaromatic Compounds With Pyrene-Labeled Starch Nanoparticles |
JP6035633B2 | Phosphate-Crosslinked Starch Nanoparticles And Use For Drug Delivery |
JP2021519310A | Aptamer Bioconjugate Drug Delivery Device |
BR112020016701A2 | Aptamer Bioconjugate Drug Delivery Device |
US20190374469A1 | Arzneimittelabgabevorrichtung Für Ein Aptamer-Biokonjugat |
AT1231177T | Dental Imaging System And Image Analysis |
WO2022187654A1 | Humectant And/Or Buffered Starch Compositions And Use In Oral Care Such As Treating Xerostomia |
WO2021102095A1 | Bisphosphonate Loaded Starch Nanoparticle |
WO2021062204A1 | Dental Imaging And/Or Curing System |
WO2019191456A1 | Phosphate Crosslinked Starch Nanoparticle And Dental Treatments |
What are GreenMark Biomedical key innovation segments?
What Technologies are Covered by GreenMark Biomedical?
The chart below distributes patents filed by GreenMark Biomedical